A SMAD6 genetic uptake of 4.6% was reached in more severely affected BAV-related aortopathy patients, i.e., BAV patients who underwent surgical repair for aneurysmal disease before the age of 50, and with a positive family history for cardiovascular disease. The gene discussed is SMAD6; the disease is cardiovascular disorder.